Gastrointestinal Stromal Tumour (GIST) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors (GISTs) Intervention: Drug: Regorafenib Sponsor: Asan Medical Center Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2016 Category: Research Source Type: clinical trials
Sarcopenia in Patients With Gastrointestinal Stromal Tumours
Condition: Gastrointestinal Stromal Tumours Intervention: Other: Computed tomography Sponsor: CHU de Reims Completed - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2016 Category: Research Source Type: clinical trials